Valuation: Amgen Inc.

Market Cap 226B 196B 184B 167B 315B 21,560B 320B 2,161B 844B 10,792B 848B 830B 36,002B P/E 2026 *
26.4x
P/E 2027 * 23.6x
Enterprise Value 268B 232B 217B 198B 373B 25,536B 379B 2,560B 999B 12,783B 1,005B 983B 42,642B EV / Sales 2026 *
6.88x
EV / Sales 2027 * 6.55x
Free-Float
99.78%
Yield 2026 *
2.41%
Yield 2027 * 2.55%
1 day+0.40%
1 week+3.21%
Current month+8.48%
1 month+15.92%
3 months+24.19%
6 months+13.18%
Current year+27.66%
1 week 406.42
Extreme 406.42
421.79
1 month 353.95
Extreme 353.95
421.79
Current year 318.21
Extreme 318.21
421.79
1 year 269.77
Extreme 269.77
421.79
3 years 248.38
Extreme 248.38
421.79
5 years 198.64
Extreme 198.64
421.79
10 years 133.64
Extreme 133.64
421.79
Manager TitleAgeSince
Chief Executive Officer 63 2012-04-30
Director of Finance/CFO 62 2010-05-12
Director of Finance/CFO 67 2019-12-31
Director TitleAgeSince
Chairman 63 2012-12-31
Director/Board Member 65 2011-12-31
Director/Board Member 71 2011-12-31
Date Insider Type Main position Quantity % Market Cap.
8/7/26 Free

Director

85 0.0000%
8/7/26 Free

Director

103 0.0000%
8/7/26 Free

Director

64 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.40%+3.21%+44.42%+59.17% 225B
-0.92%+1.43%+83.05%+128.86% 1,088B
+0.47%+1.98%+50.26%+50.75% 629B
+0.83%+2.85%+24.49%+64.82% 440B
-0.88%-0.66%+45.09%+36.64% 359B
-0.37%-1.15%+26.89%+36.31% 291B
+0.05%-1.20%+2.31%+6.15% 245B
-0.42%+1.58%-8.48%-51.94% 204B
+1.67%+5.56%+14.98%+72.68% 168B
+1.86%+2.29%+6.52%-25.64% 150B
Average +0.09%+1.68%+28.95%+37.78% 379.92B
Weighted average by Cap. -0.12%+1.49%+44.49%+62.35%

Financials

2026 *2027 *
Net sales 38.89B 33.71B 31.6B 28.81B 54.22B 3,712B 55.08B 372B 145B 1,858B 146B 143B 6,198B 40B 34.67B 32.5B 29.64B 55.77B 3,818B 56.66B 383B 149B 1,911B 150B 147B 6,375B
Net income 8.6B 7.45B 6.99B 6.37B 11.99B 821B 12.18B 82.26B 32.11B 411B 32.28B 31.58B 1,370B 9.39B 8.14B 7.63B 6.96B 13.1B 897B 13.31B 89.87B 35.09B 449B 35.27B 34.5B 1,497B
Net Debt 41.67B 36.12B 33.86B 30.87B 58.09B 3,977B 59.02B 399B 156B 1,991B 156B 153B 6,641B 36.01B 31.22B 29.26B 26.68B 50.21B 3,437B 51.01B 345B 135B 1,721B 135B 132B 5,739B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
26-08-13 US$417.84 +0.40% 2,777,885
26-08-12 US$416.18 +0.45% 2,065,699
26-08-11 US$414.30 -0.70% 2,029,780
26-08-10 US$417.20 +1.52% 1,959,757
26-08-07 US$410.95 +1.51% 1,821,551
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
417.84USD
Average target price
383.66USD
Spread / Average Target
-8.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMGN Stock